{
  "subset": "contraindication",
  "disease": "Distal myopathies",
  "relation": "contraindication",
  "gold_drugs": [
    "cyproheptadine"
  ],
  "seeds_initial": [
    "Corticosteroids",
    "Dantrolene",
    "Statins",
    "Quinine",
    "Doxorubicin",
    "Chloroquine",
    "Nonsteroidal anti-inflammatory drugs (NSAIDs)",
    "Muscle relaxants",
    "Anabolic steroids",
    "Gemfibrozil",
    "Beta-blockers",
    "Rapamycin",
    "Interferon",
    "Ciprofloxacin",
    "Colchicine",
    "Tetracycline",
    "Erythromycin",
    "Vancomycin",
    "Carbamazepine",
    "Phenytoin",
    "Valproic acid",
    "Aminoglycosides",
    "Sotalol",
    "Furosemide",
    "Digoxin",
    "L-dopa",
    "Propranolol",
    "Amiodarone",
    "Clindamycin",
    "Moxifloxacin",
    "Atorvastatin",
    "Zafirlukast",
    "Tramadol",
    "Cyclophosphamide",
    "Hydroxychloroquine",
    "Trazodone",
    "Oseltamivir",
    "Nitrofurantoin",
    "Ibuprofen",
    "Acetaminophen",
    "Ketorolac",
    "Methylprednisolone",
    "Antipsychotics",
    "Azathioprine",
    "Mycophenolate mofetil",
    "Fluoroquinolones",
    "Lithium",
    "Venlafaxine",
    "Duloxetine",
    "Clozapine",
    "Thioridazine",
    "Olanzapine",
    "Risperidone",
    "Citalopram",
    "Sertraline",
    "Escitalopram",
    "Bupropion",
    "Mirtazapine",
    "Pamidronate",
    "Zoledronic acid"
  ],
  "seed_history": [
    [
      "Corticosteroids",
      "Dantrolene",
      "Statins",
      "Quinine",
      "Doxorubicin",
      "Chloroquine",
      "Nonsteroidal anti-inflammatory drugs (NSAIDs)",
      "Muscle relaxants",
      "Anabolic steroids",
      "Gemfibrozil",
      "Beta-blockers",
      "Rapamycin",
      "Interferon",
      "Ciprofloxacin",
      "Colchicine",
      "Tetracycline",
      "Erythromycin",
      "Vancomycin",
      "Carbamazepine",
      "Phenytoin",
      "Valproic acid",
      "Aminoglycosides",
      "Sotalol",
      "Furosemide",
      "Digoxin",
      "L-dopa",
      "Propranolol",
      "Amiodarone",
      "Clindamycin",
      "Moxifloxacin",
      "Atorvastatin",
      "Zafirlukast",
      "Tramadol",
      "Cyclophosphamide",
      "Hydroxychloroquine",
      "Trazodone",
      "Oseltamivir",
      "Nitrofurantoin",
      "Ibuprofen",
      "Acetaminophen",
      "Ketorolac",
      "Methylprednisolone",
      "Antipsychotics",
      "Azathioprine",
      "Mycophenolate mofetil",
      "Fluoroquinolones",
      "Lithium",
      "Venlafaxine",
      "Duloxetine",
      "Clozapine",
      "Thioridazine",
      "Olanzapine",
      "Risperidone",
      "Citalopram",
      "Sertraline",
      "Escitalopram",
      "Bupropion",
      "Mirtazapine",
      "Pamidronate",
      "Zoledronic acid"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H1_round3",
        "key_assumptions": [
          "Corticosteroids 通过影响肌肉功能加重 Distal Myopathies",
          "存在较高的安全性风险，如感染"
        ],
        "caveats": [
          "对 Distal Myopathies 的影响需考量其他潜在风险"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_dantrolene",
          "name": "Dantrolene"
        },
        "score": 0.72,
        "graph_snapshot_ref": "GE_H2_round3",
        "key_assumptions": [
          "Dantrolene 作用于肌肉功能并可能导致肌肉损伤",
          "安全性问题未得到充分验证"
        ],
        "caveats": [
          "需监测使用后的肌肉无力症状"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "score": 0.68,
        "graph_snapshot_ref": "GE_H3_round3",
        "key_assumptions": [
          "Statins 有潜力减缓 Distal Myopathies 的病程",
          "潜在的肌肉损伤风险需考虑"
        ],
        "caveats": [
          "具体效果及风险仍需进一步研究"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Skeletal Muscle→Distal Myopathies",
          "reason": "找到明确的机制连通性，能够支持对每个假设的推导"
        }
      ],
      "remaining_gaps": [
        "对 Dantrolene 和 Statins 的安全性评估尚不充分"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "seed_a",
            "seed_b",
            "seed_c"
          ],
          "impact_summary": "提供了关于药物对 Distal Myopathies 影响的初步数据"
        },
        {
          "round": 2,
          "seeds": [
            "seed_d",
            "seed_e"
          ],
          "impact_summary": "增强了机制链的探索，通过比较药物效果与风险揭示出新的方向"
        }
      ],
      "lessons": [
        "针对 Distal Myopathies 的药物投放需要考虑每种药物的潜在风险与好处",
        "保持对药物机制研究的持续关注，以应对复杂的安全性问题"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "强调药物对 Distal Myopathies 的潜在风险与利益平衡"
      },
      {
        "role": "Skeptic",
        "patch": "呼吁对安全性问题进行严格审查，特别是在使用 Dantrolene 和 Statins 时"
      }
    ],
    "heuristics": [
      {
        "when": "评估 Distal Myopathies 治療选项时",
        "then": "需要对每种药物进行细致的效益与风险分析"
      }
    ]
  }
}